Jeffrey J. Kirshner MD, FACP, FASCO
Medical Oncologist, Hematology Oncology Associates of Central New York (HOACNY), East Syracuse, New YorkDr. Jeffrey J. Kirshner is a Medical Oncologist at Hematology Oncology Associates of Central New York (HOACNY) in East Syracuse and serves as an Investigator in Alliance for Clinical Trials in Oncology. He is an author or co-author of over 75 peer reviewed research publications. He has an active clinical practice as well, currently specializing in Breast Cancer.
Dr. Kirshner has a strong interest in patient care and is actively involved in clinical research. He is also an active volunteer in Alliance and ASCO. He currently serves as the chair of the DSMB for Alliance and is a member of several committees: Breast Committee, Symptom Intervention Committee and Community Oncology Committee. He is a member of the ASCO Practice Guidelines Implementation Network and serves as the community oncology representative on four expert panels and the Cancer Survivorship Guidelines Advisory Group.
Positions:
Medical Oncologist, Hematology Oncology Associates of Central New York, East Syracuse
Past Director of Research, Hematology Oncology Associates of Central New York, East Syracuse
Attending Physician, Crouse Hospital, Syracuse
Attending Physician, St. Joseph’s Hospital and Health Center, Syracuse
Clinical Associate Professor, SUNY Upstate Medical University, Syracuse
Degree:
Lehigh University, BA
University of Pennsylvania School of Medicine, MD
Postgraduate Training:
Resident, SUNY Upstate Medical Center
Fellow, SUNY Upstate Medical Center
Board Certifications:
Internal medicine
Medical oncology
Hematology
Clinical Interests:
Medical oncology/hematology, clinical trials
Disclosures
Dr. Kirshner reports no relevant disclosures at this time.
Recent Contributions to PracticeUpdate:
- ASCO 2020: Abstract Recommendations From Dr. Jeffrey Kirshner for Symptoms and Survivorship
- 2019 Top Stories in Oncology: Atezolizumab Plus Chemotherapy for Triple-Negative Breast Cancer
- Ten Practice Changes That I Will Make After Attending ASCO 2019
- ASCO 2019: Abstract Recommendations From Dr. Jeffrey Kirshner for Symptom Control
- Ten Practice Changes That I Will Make After Attending ASCO 2018
- 2018 Top Stories in Oncology: ER-Positive, Node-Negative Breast Cancer
- ESMO 2018: Recommendations From Dr. Jeffrey Kirshner
- 2017 Top Stories in Oncology: IDEA—Duration of Adjuvant Therapy in Stage III Colon Cancer
- Skin Cancer Updates: Select Trials Reviewed
- Biosimilars to Trastuzumab and Bevacizumab Up for Approval